Iabl

Established in 1977, Iabl stands as Bangladesh's largest healthcare provider, with a significant focus on the diabetes field and an unwavering commitment to compliance and ethical practices. The company plays a crucial role in the nation's pharmaceutical landscape by marketing a diverse portfolio of life-saving drugs. Iabl also serves as a vital marketing and distribution partner for prominent multinational corporations, including Eli Lilly and CSL Behring, leveraging its extensive reach. Its operations are underpinned by a robust distribution network that effectively covers all 64 districts of Bangladesh, ensuring broad accessibility to essential medicines and healthcare products. The company has successfully expanded its capabilities to include its own cGMP standard pharmaceutical manufacturing facility, demonstrating a commitment to quality and vertical integration within the sector.

With a dedicated workforce of over 800 individuals, Iabl operates within the employee range of 500 - 1,000 employees, reflecting its substantial operational scale and market presence. This team is instrumental in driving the company's mission to improve health outcomes across the country. Meet Iabl's team to gain insight into the professionals powering this leading healthcare organization. The company's strategic expansion into pharmaceutical manufacturing, adhering to cGMP standards, highlights its ambition to enhance its contribution to public health and its position as a key player in the healthcare ecosystem. This integrated approach allows for greater control over product quality and supply chain efficiency.

Iabl's product offerings are centered around critical therapeutic areas, notably including various insulin formulations essential for diabetes management, alongside a range of nutritional supplements designed toView more...